Regulation of plasminogen activator inhibitor-1 secretion by growth factors in smooth muscle cells

Blood Coagulation and Fibrinolysis

Volumn 13, Issue 6, 2002, Pages 541-549

  Lau, Herbert K F ^a   Ho, J ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Basic fibroblastgrowth factor; Plasminogen activator inhibitor 1; Platelet derived growth factor; Signal transduction; Smooth muscle cells

Indexed keywords

GROWTH FACTOR; INOSITOL PHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHOTRANSFERASE INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; PROTEINASE INHIBITOR; RAF PROTEIN; ENZYME PRECURSOR; FIBROBLAST GROWTH FACTOR 2; GROWTH PROMOTOR; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE SYK; SIGNAL PEPTIDE;

ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME MECHANISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; ANIMAL; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; METABOLISM; PHYSIOLOGY; RAT; SECRETION; VASCULAR SMOOTH MUSCLE;

ANIMALS; CAROTID ARTERIES; ENZYME PRECURSORS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; GROWTH SUBSTANCES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE SIGNALING SYSTEM; MUSCLE, SMOOTH, VASCULAR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET-DERIVED GROWTH FACTOR; PROTEIN-TYROSINE KINASES; RATS; SIGNAL TRANSDUCTION;

EID: 0036742081     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200209000-00009     Document Type: Article

References (42)

1. Wohrley J, Frid M, Moiseeva E, Orton EC, Belknap JK, Stenmark KR. Hypoxia selectively induces proliferation in a specific subpopulation of smooth muscle cells in the bovine neonatal pulmonary arterial media. J Clin Invest 1996; 96: 273-281.
2. Orlandi A, Ehrlich HP, Ropraz P, Spagnoli LG, Gabbiani G. Rat aortic smooth muscle cells isolated from different layers and at different times after endothelial denudation show distinct biological features in vitro. Arterioscler Thromb 1994; 14: 982-989.
3. Frid MG, Moiseeva EP, Stenmark KR. Multiple phenotypically distinct smooth muscle cell populations exist in the adult and developing bovine pulmonary arterial media in vivo. Circ Res 1994; 75: 669-681.
4. Majesky MW, Giachelli CM, Reidy MA, Schwartz SM. Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury. Circ Res 1992; 71: 759-768.
5. Bochaton-Piallat M-L, Gabbiani F, Ropraz P, Gabbiani G. Age influences the replicative activity and the differentiation features of cultured rat aortic smooth muscle cell populations and clones. Arterioscler Thromb 1993; 13: 1449-1455.
6. Aikawa M, Sivam P, Kuro-o M, Kimura K, Nakahara K, Takewaki S et al. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ Res 1993; 73: 1000-1012.
7. Bochaton-Piallat M-L, Ropraz P, Gabbiani F, Gabbiani G. Phenotypic heterogeneity of rat arterial smooth muscle cell clones. Implications for the development of experimental intimal thickening. Artherioscler Thromb Vasc Biol 1996; 16: 815-820.
8. Schneiderman J, Sawdey MS, Keeton MR, Bordin GM, Bernstein EF, Dilley RB, Loskutoff DJ. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci USA 1992; 89: 6998-7002.
9. Lupu F, Bergozelli GE, Heim DA, Cousin E, Genton CY, Bachmann F, Kruithof EKO. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arterioscler Thromb 1993; 13: 1090-1100.
10. Reidy MA, Irvin C, Lindner V. Migration of arterial wall cells: expression of plasminogen activators and inhibitors in injured rat arteries. Circ Res 1996; 78: 405-414.
11. Hasenstab D, Forough R, Clowes AW. Plasminogen activator inhibitor type 1 and tissue inhibitor of metalloproteinases-2 increase after arterial injury in rats. Circ Res 1997; 80: 490-496.
12. Gray RP, Yudkin JS, Patterson DLH. Plasminogen activator inhibitor: a risk factor for myocardial infarction in diabetic patients. Br Heart J 1993; 69: 228-232.
13. Hamsten A, Walldius G, Szamosi A, Blomback M, Faire U, Dahlen G, et al. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; 2: 3-9.
14. Potter van Loon BJ, Kluft C Radder JK, Blankenstein MA, Meinders AE. The cardiovascular risk factor plasminogen activator inhibitor type I is related to insulin resistence. Metabolism 1993; 42: 945-949.
15. McGill JN, Schneider DJ, Arfken CL, Lucore CL, Sobel BE. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes 1994; 43: 104-109.
16. Lau HKF, Teitel JM, Cheung T, Kung SKP, Garvey MB. Hypofibrinolysis in patients with hypercoagulability: the roles of urokinase and plasminogen activator inhibitor. Am J Hematol 1993; 44: 260-265.
17. Strauss BH, Lau HKF, Bowman KA, Sparkes J, Chisholm RJ, Garvey MB, et al. Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis. Circulation 1999; 100: 1616-1622.
18. Lau, HKF. Regulation of proteolytic enzymes and inhibitors in two smooth muscle cell phenotypes. Cardiovasc Res 1999; 43: 1049-1049.
19. Wojta J, Gallicchio M, Zoellner H, Hufnagl P, Last K, Filonzi EL, et al. Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells. Thromb Haemost. 1993; 70: 469-474.
20. Cockell, KA, Ren S, Sun J, Angel A, Shen GX. Effect of thrombin on release of plasminogen activator inhibitor-1 from cultured primate arterial smooth muscle cells. Thromb Res 1995; 77: 119-131.
21. van Leeuwen RUJ, Kol A, Kluft C, Maseri A, Sperti G. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells. Circulation 1994; 90: 362-368.
22. Ren S, Cockell KA, Fenton JW 2nd, Angel A, Shen GX. G proteins and phospholipase C mediate thrombin-induced generation of plasminogen activator inhibitor-1 from vascular smooth muscle cells. J Vasc Res 1997; 34: 82-89.
23. Jones LG, Ella KM., Bradshaw CD, Gause KC, Dey M, Wisehart-Johnson AE, et al. Activation of mitogen-activated protein kinases and phospholipase D in A7r5 vascular smooth muscle cells. J Biol Chem 1994; 269: 23790-23799.
24. Laemmli UK. Cleavage of structural proteins during assembly of head bacteriophage T4. Nature 1970; 227: 680-682.
25. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992; 258: 607-614.
26. Crowell PL, Ren Z, Lin S, Vadejs E, Gould MN. Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation. Biochem Pharmacol 1994; 47; 1405-1415.
27. Marshall CJ. Opportunities for pharmacological intervention in the ras pathway. Ann Oncol 1995; 6 (suppl 1); 63-67.
28. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, et al. Protein kinase C (alpha) activates RAF-1 by direct phosphorylation. Nature 1993; 364: 249-252.
29. Carroll MP, May WS. Protein kinase C-mediated serine phosphorylation directly activates Raf-1 in murine hematopoietic cells. J Biol Chem 1994; 269: 1249-1256.
30. Ueda Y, Hirai S, Osada S, Suzuki A, Mizuno K, Ohno S. Protein kinase C δ activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J Biol Chem 1966; 271: 23512-23519.
31. Arai H, Escobedo JA. Angiotensin II type 1 receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism. Mol Pharmacol 1996; 50: 522-528.
32. Schulz S, Reinhold D, Schmidt H, Ansorge S, Holt V. Perillic acid inhibits Ras/MAP kinase-driven IL-2 production in human T lymphocytes. Biochem Biophys Res Commun 1997; 241: 720-725.
33. 2+ channels in adult bullfrog sympathetic neurons by nerve growth factor. J Neurophysiol 1998; 80: 1352-1361.
34. Zheng CF, Ohmichi M, Saltiel AR, Guan KL. Growth factor induced MEK activation is primarily mediated by an activator different from c-raf. Biochemistry 1994; 33: 5595-5599.
35. Kinane TN, Kang I, Chu A, Chin SH, Erolani L. G appha(i-2) mediates renal LLC-PK1 growth by a Raf-independent activation of p42/p44 MAP kinase. Am J Physiol 1997; 272 (2 part 2): F273-F282.
36. Rhoads JM, Argenzio RA, Chen W, Graves LM, Licato LL, Blikspager AT, et al. Glutamine metabolism stimulates intestinal cell MAPKs by a cAMP-inhibitable, Raf-independent mechanism. Gastroenterology 2000; 18: 90-100.
37. Chen Y-H, Pouyssegur J, Courtneidge SA, Van Obberhgen-Schilling E. Activation of Src family kinase activity by the G protein-coupled thrombin receptor in growth-responsive fibroblasts. J Biol Chem 1994; 269: 27372-27377.
38. Chaudhary LR, Hruska KA. The cell survival signal Akt is differentially activated by PDGF-BB, EGF, and FGF-2 in osteoblastic cells. J Cell Biochem 2001, 81: 304-311.
39. Yim SY, Hammer JA, Quarles RH. Differences in signal transduction pathways by which platelet-derived and fibroblast growth factors activate extracellular signal-regulated kinase in differentiating oligodendrocytes. J Neurochem 2001; 76: 1925-1934.
40. Raeder EMB, Mansfield PJ, Hinkovska-Galcheva V, Shargman JA, Boxer LA. Syk activation initiates downstream signaling events during human polymorphonuclear leukocytes phagocytosis. J Immunol 1999; 163: 6785-6793.
41. Breton A, Descoteaux A. Protein kinase C-a participates in Fc?R-mediated phagocytosis in macrophages. Biochem Biophys Res Commun 2000; 276: 472-476.
42. Walker LN, Bowen-Pope DG, Ross R, Redidy MA. Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci USA 1986; 83: 7311-7315.